TY - JOUR
T1 - Thioredoxin Reductase 1 Modulates Pigmentation and Photobiology of Murine Melanocytes in vivo
AU - Carpenter, Evan L.
AU - Wyant, Mark B.
AU - Indra, Aaryan
AU - Ito, Shosuke
AU - Wakamatsu, Kazumasa
AU - Merrill, Gary F.
AU - Moos, Philip J.
AU - Cassidy, Pamela B.
AU - Leachman, Sancy A.
AU - Ganguli-Indra, Gitali
AU - Indra, Arup K.
N1 - Funding Information:
We would like to thank Indra laboratory members past and present as well as work done by Gail Kent in the Leachman-Cassidy Laboratory. We also thank Lionel Larue from Institut Curie (Paris, France) for the Tyr-Cre mice used in this study. Research reported in this publication was supported in part by the National Institute of Environmental Health Sciences of the National Institutes of Health under the award number 1R01ES016629-01A1 (principal investigator: AKI), the Oregon State University/Oregon Health & Science University College of Pharmacy Pilot Project Grant (principal investigator: AKI) and Training grant from National Center for Complementary and Integrative Health of the National Institutes of Health under award number T32AT010131. Conceptualization: ELC, AKI, PBC, GFM; Data Curation: ELC, AKI; Formal Analysis: ELC, AKI; Funding Acquisition: AKI, SAL, GGI, PBC; Investigation: ELC, MBW, PBC, SI, KW, AI; Methodology: ELC, AKI, PBC; Project Administration: AKI, SAL; Resources: AKI, SAL, GFM, PJM; Supervision: AKI, SAL, GGI, PBC; Validation: ELC, AKI, PBC; Visualization: ELC, AKI, PBC; Writing - Original Draft Preparation: ELC; Writing - Review and Editing: AKI, PBC
Funding Information:
We would like to thank Indra laboratory members past and present as well as work done by Gail Kent in the Leachman-Cassidy Laboratory. We also thank Lionel Larue from Institut Curie (Paris, France) for the Tyr-Cre mice used in this study. Research reported in this publication was supported in part by the National Institute of Environmental Health Sciences of the National Institutes of Health under the award number 1R01ES016629-01A1 (principal investigator: AKI), the Oregon State University/ Oregon Health & Science University College of Pharmacy Pilot Project Grant (principal investigator: AKI) and Training grant from National Center for Complementary and Integrative Health of the National Institutes of Health under award number T32AT010131.
Publisher Copyright:
© 2021 The Authors
PY - 2022/7
Y1 - 2022/7
N2 - Pigment-producing melanocytes overcome frequent oxidative stress in their physiological role of protecting the skin against the deleterious effects of solar UV irradiation. This is accomplished by the activity of several endogenous antioxidant systems, including the thioredoxin antioxidant system, in which thioredoxin reductase 1 (TR1) plays an important part. To determine whether TR1 contributes to the redox regulation of melanocyte homeostasis, we have generated a selective melanocytic Txnrd1-knockout mouse model (Txnrd1mel‒/‒), which exhibits a depigmentation phenotype consisting of variable amelanotic ventral spotting and reduced pigmentation on the extremities (tail tip, ears, and paws). The antioxidant role of TR1 was further probed in the presence of acute neonatal UVB irradiation, which stimulates melanocyte activation and introduces a spike in oxidative stress in the skin microenvironment. Interestingly, we observed a significant reduction in overall melanocyte count and proliferation in the absence of TR1. Furthermore, melanocytes exhibited an elevated level of UV-induced DNA damage in the form of 8-oxo-2’-deoxyguanosine after acute UVB treatment. We also saw an engagement of compensatory antioxidant mechanisms through increased nuclear localization of transcription factor NRF2. Altogether, these data indicate that melanocytic TR1 positively regulates melanocyte homeostasis and pigmentation during development and protects against UVB-induced DNA damage and oxidative stress.
AB - Pigment-producing melanocytes overcome frequent oxidative stress in their physiological role of protecting the skin against the deleterious effects of solar UV irradiation. This is accomplished by the activity of several endogenous antioxidant systems, including the thioredoxin antioxidant system, in which thioredoxin reductase 1 (TR1) plays an important part. To determine whether TR1 contributes to the redox regulation of melanocyte homeostasis, we have generated a selective melanocytic Txnrd1-knockout mouse model (Txnrd1mel‒/‒), which exhibits a depigmentation phenotype consisting of variable amelanotic ventral spotting and reduced pigmentation on the extremities (tail tip, ears, and paws). The antioxidant role of TR1 was further probed in the presence of acute neonatal UVB irradiation, which stimulates melanocyte activation and introduces a spike in oxidative stress in the skin microenvironment. Interestingly, we observed a significant reduction in overall melanocyte count and proliferation in the absence of TR1. Furthermore, melanocytes exhibited an elevated level of UV-induced DNA damage in the form of 8-oxo-2’-deoxyguanosine after acute UVB treatment. We also saw an engagement of compensatory antioxidant mechanisms through increased nuclear localization of transcription factor NRF2. Altogether, these data indicate that melanocytic TR1 positively regulates melanocyte homeostasis and pigmentation during development and protects against UVB-induced DNA damage and oxidative stress.
UR - http://www.scopus.com/inward/record.url?scp=85123572300&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123572300&partnerID=8YFLogxK
U2 - 10.1016/j.jid.2021.11.030
DO - 10.1016/j.jid.2021.11.030
M3 - Article
C2 - 35031135
AN - SCOPUS:85123572300
SN - 0022-202X
VL - 142
SP - 1903-1911.e5
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 7
ER -